India Globalization Capital Inc Warrants 03/06/2017

(IGCI.W)

By |

Profile

India Globalization Capital Inc is engaged in the development of cannabis-based combination therapies to treat Alzheimer's, pain, nausea, eating disorders, several endpoints of Parkinson's, and epilepsy in humans, dogs, and cats. The company has focused on four products that it is preparing for medical trials, Natrinol, Caesafin, Serosapse, and Hyalolex.

Contact Information

Website: www.igcinc.us
Email: info@igcinc.us
Main Phone: +1 301 983-0998
Address: 4336 Montgomery Avenue
State: MD
City / Town: Bethesda
Country: USA
Postal Code: 20814

Issuer Information

Exchange: OTO
CEO: Ram Mukunda
Employees: 26
NAICS: Pharmaceutical Preparation Manufacturing(325412)
(%)
Company data no longer available
Last Price N/A Change $ N/A Change % N/A Tick N/A
Bid N/A Bid Size N/A Ask N/A Ask Size N/A
Open N/A High N/A Low N/A Prev Close N/A
Last Trade Volume 0 52 Wk Hi N/A 52 Wk Low N/A
Market Cap N/A Ex-Div Date N/A Div Rate N/A Yield N/A
Shares N/A EPS (TTM) N/A PE Ratio N/A Exchange OTCPK